Omongos, Emelia R.

HRN: 06-04-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/31/2023
02/07/2023
IV
1.5g
Q6H
Pressure Ulcer Grade IV
Waiting Final Action 
03/04/2023
CEFTRIAXONE 1G (VIAL)
03/04/2023
03/11/2023
IV
2g
OD
Aspiration Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: